Global Benign Prostatic Hyperplasia Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.



Scope of the Report:

This report focuses on the Benign Prostatic Hyperplasia Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications

The worldwide market for Benign Prostatic Hyperplasia Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.



Market Segment by Manufacturers, this report covers

Lumenis

Olympus corporation

Urologix

Boston Scientific corporation

Lisa Laser

Medifocus

Neotrac

ProArc Medical LTD

Urotech GMBH



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Transurethral Resection of the Prostate (TURP)

Transurethral Microwave Therapy (TUMT)

Transurethral Needle Ablation of the Prostate (TUNA)

Laser Surgery

Prostatic Stenting

Others



Market Segment by Applications, can be divided into

Hospitals and Clinics

Ambulatory Surgical Centers(ASC)

Home

Others



There are 15 Chapters to deeply display the global Benign Prostatic Hyperplasia Devices market.

Chapter 1, to describe Benign Prostatic Hyperplasia Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Benign Prostatic Hyperplasia Devices, with sales, revenue, and price of Benign Prostatic Hyperplasia Devices, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Benign Prostatic Hyperplasia Devices, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Benign Prostatic Hyperplasia Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Benign Prostatic Hyperplasia Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions